Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Viking Therapeutics Inc (VKTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH498682FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective androgen receptor modulator developed for the treatment of lean body mass loss in patients who have undergone hip fracture surgery. Its other pipeline product candidates include VK0214 for the treatment of orphan indication, a rare X-linked inherited neurological disorder; VK2809 developed for orally available tissue and receptor-subtype selective agonist of the thyroid beta receptor for the treatment of hypercholesterolemia and fatty liver disease; and VK0612, an inhibitor of fructose -1,6-biphosphatase for type 2 diabetes. Viking Therapeutics is headquartered in San Diego, California, the US.

Viking Therapeutics Inc Key Recent Developments

Apr 07,2021: Viking Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
Feb 17,2021: Viking Therapeutics reports fourth quarter and year-end 2020 financial results and provides corporate update
Feb 10,2021: Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021
Jan 13,2021: Viking Therapeutics Announces Senior Management Team Appointments

This comprehensive SWOT profile of Viking Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Viking Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Viking Therapeutics Inc – Key Information
Viking Therapeutics Inc – Overview
Viking Therapeutics Inc – Key Employees
Viking Therapeutics Inc – Key Employee Biographies
Viking Therapeutics Inc – Key Operational Heads
Viking Therapeutics Inc – Major Products and Services
Viking Therapeutics Inc – History
Viking Therapeutics Inc – Company Statement
Viking Therapeutics Inc – Locations And Subsidiaries
Viking Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Viking Therapeutics Inc – Business Description
Viking Therapeutics Inc – Corporate Strategy
Viking Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Viking Therapeutics Inc – Strengths
Viking Therapeutics Inc – Weaknesses
Viking Therapeutics Inc – Opportunities
Viking Therapeutics Inc – Threats
Viking Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Viking Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Viking Therapeutics Inc, Key Information
Viking Therapeutics Inc, Key Ratios
Viking Therapeutics Inc, Share Data
Viking Therapeutics Inc, Major Products and Services
Viking Therapeutics Inc, History
Viking Therapeutics Inc, Key Employees
Viking Therapeutics Inc, Key Employee Biographies
Viking Therapeutics Inc, Key Operational Heads
Viking Therapeutics Inc, Other Locations
Viking Therapeutics Inc, Subsidiaries
Viking Therapeutics Inc, Key Competitors
Viking Therapeutics Inc, SWOT Analysis
Viking Therapeutics Inc, Ratios based on current share price
Viking Therapeutics Inc, Annual Ratios
Viking Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Morgan Advanced Materials plc (MGAM):企業の財務・戦略的SWOT分析
    Summary Morgan Advanced Materials Plc (Morgan) is a diversified company. The company designs, manufactures and markets technical ceramics, thermal ceramics, molten metal systems, electrical carbon, braze alloys, fire protection products, seals and bearings, specialty graphite, and composites and def …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • BayWa AG:企業のM&A・事業提携・投資動向
    BayWa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BayWa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Bradken Pty Ltd:企業の戦略・SWOT・財務分析
    Bradken Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Bradken Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • U.S. National Geospatial-Intelligence Agency:企業の戦略的SWOT分析
    U.S. National Geospatial-Intelligence Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd is a healthcare service provider that offers Dental, Audiology, Radiology and medical services. The company also operates business in community pathology and radiology sector. It operates businesses in sectors …
  • Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mi …
  • Mission Pharmacal Company:企業の戦略的SWOT分析
    Mission Pharmacal Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Collegium Pharmaceutical Inc (COLL):製薬・医療:M&Aディール及び事業提携情報
    Summary Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative products for treating patients suffering from pain. The company develops products based on its DETERx platform technology. DETERx offers extended …
  • AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical researc …
  • AnGes Inc (4563):企業の財務・戦略的SWOT分析
    AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Keio University-製薬・医療分野:企業M&A・提携分析
    Summary Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law …
  • Sasol Limited:企業の戦略・SWOT・財務情報
    Sasol Limited - Strategy, SWOT and Corporate Finance Report Summary Sasol Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Martin Marietta Materials Inc:企業のM&A・事業提携・投資動向
    Martin Marietta Materials Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Martin Marietta Materials Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Barco NV (BAR):企業の財務・戦略的SWOT分析
    Barco NV (BAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • The Nassau Companies of New York:企業の戦略的SWOT分析
    The Nassau Companies of New York - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Biomm SA (BIOM3):企業の財務・戦略的SWOT分析
    Summary Biomm SA (Biomm), formerly Savicevic Participacoes SA is a biopharmaceutical company that research, develops, produces and markets biomedicines. The company develops processes for the production of active pharmaceutical ingredients and enzymes used in the production of biofuels. It licenses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆